IRMD (STOCKS)
iRadimed Corporation
$90.790000
-2.810000 (-3.00%)
Prev close: $93.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Roger Susi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,159.36M
- Employees
- 160
- P/E (TTM)
- 50.98
- P/B (TTM)
- 12.15
- Dividend Yield
- 79.06%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.49 | $0.45 | +0.0361 | +7.95% |
|
Dec 2025 (Q4)
|
$0.54 | $0.49 | +0.0504 | +10.29% |
|
Sep 2025 (Q3)
|
$0.47 | $0.46 | +0.0059 | +1.27% |
|
Jun 2025 (Q2)
|
$0.49 | $0.44 | +0.0463 | +10.44% |
Financial Statements
| Revenues | $86.28M |
| Benefits Costs and Expenses | $56.10M |
| Cost Of Revenue | $19.99M |
| Costs And Expenses | $56.10M |
| Gross Profit | $66.30M |
| Nonoperating Income/Loss | $2.23M |
| Operating Expenses | $38.34M |
| Research and Development | $3.31M |
| Other Operating Expenses | $35.04M |
| Operating Income/Loss | $27.95M |
| Income/Loss From Continuing Operations After Tax | $23.61M |
| Income/Loss From Continuing Operations Before Tax | $30.18M |
| Income Tax Expense/Benefit | $6.57M |
| Net Income/Loss | $23.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $23.61M |
| Net Income/Loss Available To Common Stockholders, Basic | $23.61M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.86 |
| Diluted Earnings Per Share | $1.83 |
| Basic Average Shares | 38,224,690 |
| Diluted Average Shares | 38,577,482 |
| Assets | $114.39M |
| Current Assets | $86.42M |
| Inventory | $11.88M |
| Other Current Assets | $74.54M |
| Noncurrent Assets | $27.97M |
| Fixed Assets | $24.23M |
| Other Non-current Assets | $3.74M |
| Liabilities | $15.88M |
| Current Liabilities | $12.12M |
| Accounts Payable | $2.18M |
| Wages | $2.07M |
| Other Current Liabilities | $7.87M |
| Noncurrent Liabilities | $3.76M |
| Equity | $98.51M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $98.51M |
| Liabilities And Equity | $114.39M |
| Net Cash Flow From Operating Activities | $28.95M |
| Net Cash Flow From Operating Activities, Continuing | $28.95M |
| Net Cash Flow From Investing Activities | -$4.97M |
| Net Cash Flow From Investing Activities, Continuing | -$4.97M |
| Net Cash Flow From Financing Activities | -$17.93M |
| Net Cash Flow From Financing Activities, Continuing | -$17.93M |
| Net Cash Flow | $6.04M |
| Net Cash Flow, Continuing | $6.04M |
| Comprehensive Income/Loss | $23.61M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $23.61M |
| Other Comprehensive Income/Loss | $0.00 |